Health regulators in New South Wales are cracking down on the prescribing of THC, with dozens of doctors in their sights, Cannabiz has been told.
Cannabis Clinicians Australia (CCA) and the Australian Medicinal Cannabis Association (AMCA) have already had “urgent” discussions, with a further meeting planned for next Thursday.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Elementum integer enim neque volutpat ac tincidunt vitae semper quis. Eu lobortis elementum nibh tellus molestie nunc. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Magnis dis parturient montes nascetur ridiculus. Dui id ornare arcu odio ut sem. Nisl nunc mi ipsum faucibus vitae.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Elementum integer enim neque volutpat ac tincidunt vitae semper quis. Eu lobortis elementum nibh tellus molestie nunc. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Magnis dis parturient montes nascetur ridiculus. Dui id ornare arcu odio ut sem. Nisl nunc mi ipsum faucibus vitae.
Perhaps the PSU could look into the over reach and unnecessary pharmacy compounding of Medicinal Cannabis which I assume is in their remit. When you take a more holistic view of the issuing of prescriptions for THC, the use of cannabis through the illegal market is much larger than the medical market, cracking down on prescriptions will most likely drive more users back to the street to procure product. When to comes to high THC prescriptions much of the demand exists already and the regulators won’t change that.